Published in J Pharmacol Exp Ther on March 01, 1981
5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br J Pharmacol (1984) 1.01
Increased 5-HT2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats. Br J Pharmacol (1983) 0.97
Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine- and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex. Br J Pharmacol (1983) 0.84
Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina. Proc Natl Acad Sci U S A (1982) 0.79
Some anticonvulsant drugs alter monoamine-mediated behaviour in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy. Br J Pharmacol (1985) 0.78
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain (2000) 7.95
A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med (1999) 3.58
Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry (2006) 2.52
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain (1999) 2.35
Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology (2006) 2.25
Studies of the mode of action of adrenal steroids on lymphocytes. Recent Prog Horm Res (1967) 2.09
Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci U S A (2000) 2.08
Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology (2004) 1.81
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain (1997) 1.73
Properties of adenylate cyclase of lymphoid cells. Proc Natl Acad Sci U S A (1971) 1.47
Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3':5'-cyclic monophosphate formation in intact retina. Proc Natl Acad Sci U S A (1972) 1.41
Influence of cortisol on the utilization of precursors of nucleic acids and protein by lymphoid cells in vitro. J Biol Chem (1968) 1.36
Alterations in protein and nucleic acid metabolism of thymocytes produced by adrenal steroids in vitro. J Biol Chem (1966) 1.31
Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells. Proc Natl Acad Sci U S A (1971) 1.20
Opioid and opiate immunoregulatory processes. Crit Rev Immunol (1996) 1.19
Adenyl cyclase of cultured mammalian cells: activation by catecholamines. Science (1970) 1.19
T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology (1998) 1.18
Studies concerning the interaction of serine soluble ribonucleic acid with seryl soluble ribonucleic acid synthetase from baker's yeast. Biochemistry (1966) 1.14
Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology (2006) 1.13
Evidence for induction by cortisol in vitro of a protein inhibitor of transport and phosphorylation processes in rat thymocytes. Proc Natl Acad Sci U S A (1971) 1.08
Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc Natl Acad Sci U S A (1993) 1.03
P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system. Muscle Nerve (1999) 1.01
Adenosine 3',5'-monophosphate-dependent protein kinase of cultured mammalian cells. Science (1971) 0.99
Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc Natl Acad Sci U S A (1993) 0.96
DNA vaccination with HuD inhibits growth of a neuroblastoma in mice. Clin Cancer Res (1998) 0.96
Occurrence of the opiate alkaloid-selective mu3 receptor in mammalian microglia, astrocytes and Kupffer cells. Brain Res (1995) 0.96
Resolution of cytidine- and adenosine- terminal transfer ribonucleic acids. Biochemistry (1966) 0.94
Presence of epidermal growth factor receptors and influence of epidermal growth factor on proliferation and aging in cultured smooth muscle cells. J Cell Physiol (1979) 0.94
Expression of adenylate cyclase, catecholamine receptor, and cyclic adenosine monophosphate-dependent protein kinase in synchronized culture of Chang's liver cells (S phase-membrane receptors-NaF stimulation). Proc Natl Acad Sci U S A (1972) 0.94
Pertussis toxin blocks depressant effects of opioid, monoaminergic and muscarinic agonists on dorsal-horn network responses in spinal cord-ganglion cultures. Brain Res (1987) 0.93
Cerebellar degeneration and autoimmunity to zinc-finger proteins of the cerebellum. Neurology (2002) 0.93
Continuous renewal of the axonal pathway sensor apparatus by insertion of new sensor molecules into the growth cone membrane. Curr Biol (1996) 0.92
Influence of neuroleptic drugs and apomorphine on dopamine-sensitive adenylate cyclase of retina. J Neurochem (1973) 0.92
Interaction of pergolide with central dopaminergic receptors. Proc Natl Acad Sci U S A (1980) 0.91
Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity. Proc Natl Acad Sci U S A (1974) 0.91
In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase in retina vs. brain. J Pharmacol Exp Ther (1986) 0.91
Biochemical analysis of mutants of a macrophage cell line resistant to the growth-inhibitory activity of interferon. J Cell Biol (1984) 0.90
Mediation by cyclic AMP of hormone-stimulated glycogenolysis in cultured rat astrocytoma cells. Biochem Biophys Res Commun (1972) 0.89
Inhibitory effects of cortisol and antibiotics on substrate entry and ribonucleic acid synthesis in rat thymocytes in vitro. J Biol Chem (1970) 0.89
Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome. Neurology (1998) 0.86
Evidence for selective loss of brain dopamine- and histamine-stimulated adenylate cyclase activities in rabbits with aging. Brain Res (1980) 0.84
Modulation of agonist stimulated adenylyl cyclase and GTPase activity by L-pro-L-leu-glycinamide and its peptidomimetic analogue in rat striatal membranes. Neurosci Lett (1999) 0.83
Effects of morphine on dopamine-stimulated adenylate cyclase and on cyclic GMP formation in primate brain amygdaloid nucleus. Life Sci (1976) 0.83
[Differential diagnosis of encephalitis due to anti-NMDA receptor antibodies]. Neurologia (2010) 0.83
Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions. Brain Res (1980) 0.83
Effects of glucocorticoids on thymocytes in vitro. Adv Enzyme Regul (1967) 0.82
Absence of HuD gene mutations in paraneoplastic small cell lung cancer tissue. Neurology (1998) 0.82
Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth. Clin Cancer Res (1999) 0.81
Opioid inhibition of dopamine release from nervous tissue of Mytilus edulis and Octopus bimaculatus. Science (1981) 0.81
Acetylmethadol metabolites influence opiate receptors and adenylate cyclase in amygdala. Eur J Pharmacol (1981) 0.81
Distribution of alpha-adrenergic, beta-adrenergic and dopaminergic receptors in discrete hypothalamic areas of rat. Brain Res (1982) 0.80
Alpha-1-acid (AAG, orosomucoid) glycoprotein: interaction with bacterial lipopolysaccharide and protection from sepsis. Inflammation (1997) 0.80
Striatal met-enkephalin concentration increases following nigrostriatal denervation. Biochem Pharmacol (1983) 0.80
Aging and monoamine receptors in brain. Fed Proc (1979) 0.80
Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics. J Neurooncol (1996) 0.80
2-Chloroadenosine-dependent elevation of adenosine 3',5'-cyclic monophosphate levels in rat caudate nucleus slices. Brain Res (1975) 0.80
Stimulation of adenylate cyclase in rat striatum by pergolide: influence of GTP. Eur J Pharmacol (1980) 0.80
The effects of in vivo inactivation of GABA-transaminase and glutamic acid decarboxylase on levels of GABA in the rat retina. Brain Res (1987) 0.80
Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors. Brain Res (1982) 0.80
Unilateral peri-substantia nigra catecholaminergic lesion and amygdala kindling. Brain Res (1986) 0.80
Activation of glycogen phosphorylase in rat caudate nucleus slices by L-isopropylnorepinepherine and dibutyryl cyclic AMP. J Neurochem (1977) 0.80
Dopamine stimulates rat cortical somatostatin release. Brain Res (1986) 0.79
Stimulation of glycogenolysis in rat caudate nucleus slices by L-isopropylnorepinephrine, dibutyryl cyclic AMP and 2-chloroadenosine. J Neurochem (1976) 0.79
Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina. Proc Natl Acad Sci U S A (1982) 0.79
Distribution of beta-adrenergic receptors and isoproterenol-stimulated cyclic AMP formation in monkey iris and ciliary body. Exp Eye Res (1980) 0.79
Dopamine receptor sensitivity following nigrostriatal lesion in the aged rat. Brain Res (1982) 0.78
The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy. J Neuroophthalmol (2001) 0.78
Effects of cell density and cell growth alterations on cyclic nucleotide levels in cultured human diploid fibroblasts. Exp Cell Res (1978) 0.78
p53 gene mutations in primary lung tumors are conserved in brain metastases. J Neurooncol (1992) 0.78
Effect of tunicamycin on the turnover of epidermal growth factor receptors in cultured calf aorta smooth muscle cells. Comparison with IMR-90 human lung fibroblasts. Biochim Biophys Acta (1980) 0.78
Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes. Brain Res (1979) 0.78
Use of Bevacizumab for neurological complications during initial treatment of malignant gliomas. Neurologia (2010) 0.77
Presence in neuroblastoma cells of a mu 3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides. Brain Res (1994) 0.77
Cyclic AMP in retina and caudate nucleus: influence of dopamine and other agents. Adv Cyclic Nucleotide Res (1975) 0.77
Catecholamine-sensitive adenylate cyclase in frontal cortex of primate brain. Brain Res (1976) 0.77
Absence of antibodies to non-NMDA glutamate-receptor subunits in paraneoplastic cerebellar degeneration. Neurology (1998) 0.77
Ovarian steroids increase veratridine-induced release of amino acid neurotransmitters in preoptic area synaptosomes. Brain Res (1990) 0.77
Muscarinic receptor binding and muscarinic receptor-mediated inhibition of adenylate cyclase in rat brain myelin. J Neurosci (1987) 0.77
Anterior pituitary adenylate cyclase: stimulation by dopamine and other monoamines. Eur J Pharmacol (1979) 0.77
Changes in guanine nucleotide sensitive and insensitive 3H-ADTN binding in striatum following substantia nigra lesions. Eur J Pharmacol (1980) 0.77
GTP modulation of opiate receptors in regions of rat brain and possible mechanism of GTP action. Brain Res (1980) 0.77
Properties of dopamine agonist and antagonist binding sites in mammalian retina. Brain Res (1980) 0.77
Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase. Brain Res (1986) 0.76
Cell density and receptor-adenylate cyclase relationships in the C-6 astrocytoma cell. Mol Pharmacol (1976) 0.76
Estrogen uncouples beta-adrenergic receptor from the stimulatory guanine nucleotide-binding protein in female rat hypothalamus. Endocrinology (1993) 0.76
GABAA receptor activation induces GABA and glutamate release from preoptic area. Life Sci (1995) 0.75
Estradiol plus progesterone promote glutamate-induced release of gamma-aminobutyric acid from preoptic area synaptosomes. Neuropharmacology (1992) 0.75
Stimulation of retinal adenylate cyclase by vasoactive intestinal peptide (VIP). Eur J Pharmacol (1981) 0.75
Retina contains guanine nucleotide sensitive and insensitive classes of dopamine receptors. Eur J Pharmacol (1980) 0.75
Presence of histamine and serotonin receptors associated with adenylate cyclase in cultured calf-aorta smooth muscle cells. Pharmacological characterization of the histamine response. Biochem Pharmacol (1980) 0.75
Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging. Brain Res (1980) 0.75
Effects of L-isopropylnorepinephrine, 3-isobutyl-1-methyl xanthine and dibutyryl cyclic AMP on hexose uptake and metabolism by rat striatal slices. J Neurochem (1979) 0.75
The characterization of human uterine smooth muscle cells in culture. Cell Tissue Res (1979) 0.75
Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors. Adv Biochem Psychopharmacol (1980) 0.75
Forskolin stimulates the conversion of tyrosine to dopamine in catecholaminergic neural tissue. Brain Res (1983) 0.75
Altered characteristics of striatal [3H]ADTN binding following substantia nigra lesions. Eur J Pharmacol (1982) 0.75